Scientists have created video games that add an important element of fun to the repetitive training needed to improve vision in people – including adults – with a lazy eye and poor depth perception.
Uncategorized
Valeant announces $2 billion Securities Repurchase Program
A new securities repurchase program that will allow Valeant Pharmaceuticals to make purchases up to $2 billion of its senior notes, common shares and other securities will replace the company’s expiring program, according to a company press release. The board of directors also authorized a sub-limit for the repurchase of Valeant common shares of more than 10% of the company’s public float and 5% of the company’s issued and outstanding common shares, according to the press release.
Apellis Pharmaceuticals signs agreement to acquire Potentia Pharmaceuticals
Apellis Pharmaceuticals announced today that it entered into an agreement to acquire Potentia Pharmaceuticals.
Uncategorized
NIH renews research grants on aging
The NIH has announced renewed funding of $23.4 million for 11 Edward R. Roybal Centers for Research on Applied Gerontology and the designation of two additional sites.“The Roybal Centers’ comprehensive research infrastructure facilitates collaborations among academic researchers and those in the public and private sectors who can help design and deliver novel approaches to a number of challenges of an aging society,” NIA Director Richard J. Hodes, MD, said in a press release announcing the grants that will span 5 years. “Through a range of projects, the centers seek to (Read more...)
Uncategorized
Optos reports 7% increase in third-quarter revenue
Optos totaled $170.6 million in revenue and operating income in the third quarter, a 7% increase from $159.5 million in the third quarter 2013, according to a press release.Adjusted profit before tax doubled to $18.5 million, compared with $9.2 million…
Macular degeneration may respond to new laser therapy
A new study shows how a new type of laser treatment reduces some of the vision loss changes caused by age-related macular degeneration (AMD) without damaging the retina.